Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 6 weeks to 24 Months.~* First episode of wheezing~* Fever, cough and watery nasal discharge~Exclusion Criteria :~* Any underlying cardiovascular disease.~* Prior wheezing.~* Clinical Severity Score \> 9.~* Atopic dermatitis, allergic rhinitis or asthma.~* Oxygen saturation (SpO2) \<85% on room air.~* Obtunded consciousness.~* Previous treatment with bronchodilators within 4 hours.~* Any steroid therapy within 48 Hours.

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 2 Years
- Healthy Volunteers: f

Study Arms:
- Standard Treatment (Type: PLACEBO_COMPARATOR): L-Epinephrine and Normal Saline (0.9%)
- Study Treatment (Type: ACTIVE_COMPARATOR): L-Epinephrine and Hypertonic Saline (3%)

Based on this trial design, predict the completion outcome and termination type (if applicable).